Continuous Positive Airway Pressure for Central Sleep Apnea and Heart Failure
Open accessThe DOI matches its Crossref record; 43 of the 45 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure trial tested the hypothesis that continuous positive airway pressure (CPAP) would improve the survival rate without heart transplantation of patients who have central sleep apnea and heart failure. METHODS: After medical therapy was optimized, 258 patients who had heart failure (mean age [+/-SD], 63+/-10 years; ejection fraction, 24.5+/-7.7 percent) and central sleep apnea (number of episodes of apnea and hypopnea per hour of sleep, 40+/-16) were randomly assigned to receive CPAP (128 patients) or no CPAP (130 patients) and were followed for a mean of two years. During follow-up, sleep studies were conducted and measurements of the ejection fraction, exercise capacity, quality of life, and neurohormones were obtained. RESULTS: Three months after undergoing randomization, the CPAP group, as compared with the control group, had greater reductions in the frequency of episodes of apnea and hypopnea (-21+/-16 vs. -2+/-18 per hour, P<0.001) and in norepinephrine levels (-1.03+/-1.84 vs. 0.02+/-0.99 nmol per liter, P=0.009), and greater increases in the mean nocturnal oxygen saturation (1.6+/-2.8 percent vs. 0.4+/-2.5 percent, P<0.001), ejection fraction (2.2+/-5.4 percent vs. 0.4+/-5.3 percent, P=0.02), and the distance walked in six minutes (20.0+/-55 vs. -0.8+/-64.8 m, P=0.016). There were no differences between the control group and the CPAP group in the number of hospitalizations, quality of life, or atrial natriuretic peptide levels. An early divergence in survival rates without heart transplantation favored the control group, but after 18 months the divergence favored the CPAP group, yet the overall event rates (death and heart transplantation) did not differ (32 vs. 32 events, respectively; P=0.54). CONCLUSIONS: Although CPAP attenuated central sleep apnea, improved nocturnal oxygenation, increased the ejection fraction, lowered norepinephrine levels, and increased the distance walked in six minutes, it did not affect survival. Our data do not support the use of CPAP to extend life in patients who have central sleep apnea and heart failure.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Clinically a high loop gain can express itself as periodic breathing, for example, at high altitude,357 or in congestive heart failure (CHF).358,359”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [359]
Citations
Cites
(2005) · Statistics for Biology and Health · doi:10.1007/0-387-27255-0_9 · Cited by 20,133
Rechtschaffen, A. (1968) · Medical Entomology and Zoology · Cited by 12,637
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Effect of carvedilol on survival in severe chronic heart failure
Packer, M., Coats, A. J. S., Fowler, M. B., Katus, H. A., Krum, H., Mohacsi, P., Rouleau, J. L., Tendera, M., Castaigne, A., Roecker, E. B., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442201 · Cited by 3,093
Redfield, M. M., Jacobsen, S. J., Burnett, J. C., Mahoney, D. W., Bailey, K. R., & Rodeheffer, R. J. (2003) · JAMA · doi:10.1001/jama.289.2.194 · Cited by 3,004
Schuenemeyer, J. H., McCullagh, P., & Nelder, J. A. (1992) · Technometrics · doi:10.2307/1269238 · Cited by 2,667
McCullagh, P., & Nelder, J. A. (1983) · Springer eBooks · doi:10.1007/978-1-4899-3244-0 · Cited by 1,980
Effect of carvedilol on survival in severe chronic heart failure
Packer, M., Coats, A. J. S., & Fowler, M. B. (2001) · ACC Current Journal Review · doi:10.1016/s1062-1458(01)00477-9 · Cited by 1,661
EEG Arousals: Scoring Rules and Examples
(1992) · Sleep · doi:10.1093/sleep/15.2.173 · Cited by 1,637
Research works printed but not linked: 4
- Bradley TD, 2001, Can J Cardiol, 17, 677
- Staats BA, 1984, Am Rev Respir Dis, 130, 59
- Johnstone DE, 1994, Can J Cardiol, 10, 613
- 10.1172/jci21748 · doi:10.1172/jci21748 · Paper page
Cited by
Items 801–900 of 1,000
Terapias ventilatorias domiciliarias en el síndrome de apnea-hipopnea del sueño
Mangado, N. G., Acevedo, M. F. T., & García, T. G. (2014) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2014.06.003 · Cited by 2
“En cualquier caso, se debe tener en cuenta que existen muchos modelos de dispositivos de avance mandibular en el mercado, lo que hace difícil comparar su eficacia y extrapolar datos.”
Pérez, J. J. B., Sanz, C. Z., Ortega, R. A., García, M. G., Castro, J. L., & Novoa, M. T. (2008) · Anales de Medicina Interna · doi:10.4321/s0212-71992008000100004 · Cited by 3
“Diversos autores demostraron el beneficio del tratamiento con CPAP en SAS de tipo obstructivo (12,13) y central (17,18) en pacientes con IC, al aumentar la FE.”
BackgroundDoes beta-blocker treatment influence central sleep apnoea?
Phillips, B. A. (2008) · Yearbook of Pulmonary Disease · doi:10.1016/s8756-3452(08)70705-9 · Cited by 2
Sugimura, K., Shinozaki, T., Fukui, S., Ogawa, H., & Shimokawa, H. (2016) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.239.39 · Cited by 2
“In the CANPAP study, a randomized, continuous positive airway pressure (CPAP) had no effect on heart transplant-free survival of CHF patients with CSA (Bradley et al. 2005).”
CLINICAL HYPERTENSION AND VASCULAR DISEASES
Caralis, D. G., Bakris, G. L., Mansoor, G. A., Portman, R. J., Sorof, J. M., Ingelfinger, J. R., & White, W. B. (2005) · Cited by 2
Moon, C., Phelan, C. H., Lauver, D., & Bratzke, L. C. (2016) · Clinical Nurse Specialist · doi:10.1097/nur.0000000000000247 · Cited by 3
“Positive airway pressurewas found to improve nocturnal oxygenation, reduce left ventricular afterload, and increase the left ventricular ejection fraction.(62) Researchers have suggested that ASV is an option for treating CSA in individuals with heart failure who are resistant to other PAP therapies.”
BackgroundKardiopulmonale Komorbiditäten
Seiler, F., von Hardenberg, A., Böhm, M., Bals, R., & Maack, C. (2016) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0041-108687 · Cited by 2
Noninvasive positive ventilation in the treatment of sleep-related breathing disorders
Robert, D., & Argaud, L. (2010) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52006-7.00030-7 · Cited by 2
Sleep and Sleep–Wake Disorders
Buysse, D. J., Soehner, A. M., Abbott, S. M., Kapur, V. K., Mahowald, M. W., Parker, K. P., Honeycutt, E. F., Redline, S. S., Schenck, C. H., & Zee, P. C. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch66 · Cited by 2
Impact of Sleeping Angle on the Upper Airway and Pathogenesis of Cheyne Stokes Respiration
Hanly, P. J. (2009) · SLEEP · doi:10.1093/sleep/32.11.1412 · Cited by 5
“The Effect of Posture on Cheyne-Stokes Respirations and Hemodynamics in Patients with Heart Failure, SLEEP 2009;32(11):1499-1506.”
BackgroundSelf-citationSchlafapnoe und Herzinsuffizienz
Plenge, T., & Müller‐Ehmsen, J. (2013) · Herz · doi:10.1007/s00059-013-3878-z · Cited by 3
Central Sleep Apnea and Cardiovascular Disease
Caples, S. M. (2014) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2013.10.007 · Cited by 2
“CPAP was associated with an increase in ejection fraction and reduced risk of heart transplant only in those with CSA.39 Another trial of CPAP in HF with CSA showed reductions in catecholamine levels.40 The multicenter CANPAP Trial randomized patients with systolic HF and CSA to CPAP or no CPAP.14 Although the trial s…”
MethodInfluentialLari, F., Giostra, F., Bragagni, G., & Battista, N. D. (2010) · Italian Journal of Medicine · doi:10.1016/j.itjm.2010.01.006 · Cited by 2
Targeting Sleep Disordered Breathing to Prevent Heart Failure: What is the Evidence?
Kusunose, K., & Mehra, R. (2014) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-014-0403-8 · Cited by 2
Conduite à tenir devant un syndrome d’apnées du sommeil central
Boutin, I., Saint‐Raymond, C., Borel, J., Tamisier, R., Levy, P. A., & Pépin, J. (2009) · Revue de Pneumologie Clinique · doi:10.1016/j.pneumo.2009.07.009 · Cited by 2
Advances in the management of sleep-disordered breathing in heart failure
Matuška, P., Kára, T., Homolka, P., & Bělehrad, M. (2013) · Cor et Vasa · doi:10.1016/j.crvasa.2013.06.005 · Cited by 2
Central sleep apnea treatment in heart failure: are we counting chickens before they are hatched?
Kourouklis, S. P., & Filippatos, G. S. (2012) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.12.12 · Cited by 2
Acute hemodynamic effects of adaptive servo ventilation in patients with pulmonary hypertension
Yagi, S., Akaike, M., Iwase, T., Kusunose, K., Niki, T., Yamaguchi, K., Koshiba, K., Taketani, Y., Tomita, N., Yamada, H., et al. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.01.074 · Cited by 2
Positive Airway Pressure Treatment of Adult Patients with Obstructive Sleep Apnea
Desai, T., Khan, M. S., & Bhatt, N. Y. (2010) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2010.05.003 · Cited by 4
Tratamento da respiração de Cheyne-Stokes em pacientes com insuficiência cardíaca congestiva
Freitas, I. G. D. A., Togeiro, S. M., & Tufik, S. B. (2007) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2007000300027 · Cited by 2
Home Ventilation Therapy in Obstructive Sleep Apnea–Hypopnea Syndrome
Mangado, N. G., Acevedo, M. F. T., & García, T. G. (2014) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2014.10.010 · Cited by 2
“66 However, the only large randomized prospective study to date has been the Canadian Positive Airway Pressure Study, 67 comparing patients with heart failure and SDB randomly assigned to either CPAP or standard medical care. major differences in survival before heart transplant were found in this…”
Should All Congestive Heart Failure Patients Have a Routine Sleep Apnea Screening? Pro
Sériès, F. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.04.015 · Cited by 2
Self-citationSuri, J. C., Sen, M. K., Bhattacharya, D., Chakrabarti, S., & Gupta, N. K. (2006) · Indian Journal of Sleep Medicine · doi:10.5005/ijsm-1-2-109 · Cited by 2
“Bradley et al (63) in the CANPAP trail have shown in 250 patients that although there was decrease the AHI’s, nor epinephrine levels, improvement in mean O 2 saturation, ejection fraction and six minute walk test; there was no difference in the event rates i.e. death and heart transplantation.”
Melander, S. D., & Miller, S. (2016) · Nursing Clinics of North America · doi:10.1016/j.cnur.2015.11.004 · Cited by 2
Trupp, R. J. (2016) · AACN Advanced Critical Care · doi:10.4037/aacnacc2016815 · Cited by 2
Left Ventricular Assist Device and Drug Therapy for the Reversal of Heart Failure
Frishman, W. H. (2007) · Yearbook of Medicine · doi:10.1016/s0084-3873(08)70222-0 · Cited by 2
Adaptive Servo-Ventilation and Central Apnea Associated with Systolic Heart Failure
Shafazand, S., & Badr, M. S. (2016) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.5420 · Cited by 2
“exclusIon crIterIa: (1) Significant chronic obstructive pulmonary disease (COPD) with a forced expiratory volume in 1 second (FEV1) < 50% of predicted, (2) Oxygen saturation ≤ 90% at rest during the day, (3) Current use of positive airway pressure (PAP) therapy, (4) Life expectancy < 1 year for diseases unrelated to c…”
Physiological rationale of noninvasive mechanical ventilation use in acute respiratory failure
Prinianakis, G., Klimathianaki, M., & Georgopoulos, D. (2008) · European Respiratory Society eBooks · doi:10.1183/1025448x.00041001 · Cited by 4
“Nocturnal long-term NIMV (mainly CPAP but also adaptive servoventilation) has been used for the management of central sleep apnoea and Cheyne–Stokes respiration (CSA-CSR), which is a cardinal feature of chronic CHF [11, 63–66].”
BackgroundMethodInfluentialVazir, A., Bronis, K., & Pearse, S. G. (2016) · Cardiac failure review · doi:10.15420/cfr.2016:8:2 · Cited by 2
“It is also described in some studies to be independently associated with increased morbidity and mortality rates in patients with HF.3 Improving the underlying HF has often resulted in resolution of CSA.”
BackgroundInfluentialCorreale, M., Carpagnano, G. E., Brunetti, N. D., Forte, L., Monaco, I., Ferraretti, A., Sabato, R., Barbaro, M. P. F., Biase, M. D., & Lacedonia, D. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.12.172 · Cited by 2
“We can also hypothesize that the increased activity of RD might feature a greater tendency to develop central apnea and CSB, beyond the stage of HF. Continuous positive airway pressure (CPAP) is the treatment of choice for patients with OSA; however, the optimal management of CSA in patients with HF remains uncertain.”
InfluentialMcGrath, L. B., & Goodlin, S. J. (2017) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-017-0530-0 · Cited by 2
Effectiveness of adaptive servo-ventilation
Tomita, Y. (2015) · World Journal of Respirology · doi:10.5320/wjr.v5.i2.112 · Cited by 2
Heart Failure as a Consequence of Sleep-Disordered Breathing
Javaheri, S. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5895-3.10032-4 · Cited by 3
Mehra, R., Moul, D. E., & Strohl, K. P. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-24288-2.00108-2 · Cited by 3
Bordier, P., & Lataste, A. (2018) · Respiratory Medicine Case Reports · doi:10.1016/j.rmcr.2018.11.017 · Cited by 2
Jameria, Z. A., Mokhlesi, B., Sauser, E., Holloway, S., Upadhyay, G. A., & Nayak, H. M. (2019) · HeartRhythm Case Reports · doi:10.1016/j.hrcr.2019.10.004 · Cited by 2
Sleep apnea in chronic heart failure
Anselm, A. H., Gauthier, N., Beanlands, R. S., & Haddad, M. (2008) · Current Opinion in Internal Medicine · doi:10.1097/mci.0b013e328303e5c1 · Cited by 2
Kreitinger, K. Y., Light, M. P., Patel, S. R., & Malhotra, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-44447-1_7 · Cited by 2
Noninvasive Positive Pressure Ventilation
Joho, S. (2020) · Springer eBooks · doi:10.1007/978-981-15-4843-7_4 · Cited by 2
ATS Core Curriculum 2021. Adult Sleep Medicine: Sleep Apnea
Jamil, S. M., Shafazand, S., Dudley, K. A., Lipford, M. C., Gu, C., Jun, J. C., Budnick, I. M., Davis, E. M., Kent, D. T., Stanley, J. J., et al. (2021) · ATS Scholar · doi:10.34197/ats-scholar.2021-0027re · Cited by 3
Central Sleep Apnea: Physiotherapeutic Approach
Lino, J. A., & Piccin, V. S. (2021) · Springer eBooks · doi:10.1007/978-3-030-85074-6_17 · Cited by 2
Alterations in the Sympathetic and Parasympathetic Nervous Systems in Heart Failure
Floras, J. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-60987-6.00013-2 · Cited by 3
Self-citationВестовна, С. К., Poltavskaya, M. G., Давидович, П. А., Kuklina, M., Kharkevich, K. Y., Andreev, A., Kulikov, V. M., & Парисович, С. В. (2022) · Human Physiology · doi:10.1134/s0362119721060104 · Cited by 2
Takeishi, R., Yoshihisa, A., Hotsuki, Y., Anzai, F., Sato, Y., Sumita, Y., Nakai, M., Misaka, T., & Takeishi, Y. (2022) · Circulation Journal · doi:10.1253/circj.cj-22-0082 · Cited by 2
End-of-Life Care in the Treatment of Heart Failure in the Elderly
McClung, J. A. (2007) · Heart Failure Clinics · doi:10.1016/j.hfc.2007.07.017 · Cited by 2
Heart failure – what’s new and what’s changed?
Callan, P., & Clark, A. L. (2017) · Clinical Medicine · doi:10.7861/clinmedicine.17-4-341 · Cited by 2
Syndrome d’apnées du sommeil 1999–2022 : des essais randomisés aux études de cohorte
Levy, P. A., Tamisier, R., & Pépin, J. (2023) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2022.10.022 · Cited by 3
Treatment of central sleep apnoea with oxygen, drugs and phrenic nerve stimulation
Javaheri, S., & Germany, R. E. (2023) · European Respiratory Society eBooks · doi:10.1183/9781849841641.010622 · Cited by 2
Jaffuel, D., Philippe, C., d’Ortho, M., Bironneau, V., Perrin, C., Redolfi, S., Meurice, J.-C., Tamisier, R., Gagnadoux, F., & Launois, S. H. (2024) · Médecine du Sommeil · doi:10.1016/j.msom.2023.12.190 · Cited by 2
Central sleep apnea: emphasizing recognition and differentiation
Testelmans, D., Kalkanis, A., Papadopoulos, D., Demolder, S., & Buyse, B. (2024) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2024.2369256 · Cited by 2
“However, no significant survival difference emerged between the two groups over the 2-year follow-up [61].”
Sleep and Sleep–Wake Disorders
Abbott, S. M., Fiala, J. A., Mundt, J. M., Murray, J. M., & Standlee, J. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_62 · Cited by 2
Ventricular arrhythmia and sleep-related breathing disorders
Nazarian, S. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2010.12.043 · Cited by 2
Sleep and Quality of Life in Heart Failure and Stroke
Skobel, E. C., Norra, C., Sinha, A. M., & Randerath, W. J. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-343-5_37 · Cited by 3
“In conclusion, cardiac resynchronisation therapy is associated with a reduction in CSR, which may contribute to improved clinical outcome in patients treated with cardiac resynchronisation therapy, as Bradley and colleagues ( 88 ) reported: treatment with CPAP in patients with CHF and CSR did not affect morbidity and…”
BackgroundSleep apnoea and malignant ventricular arrhythmias in heart failure
Floras, J. S., & Andreas, S. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq338 · Cited by 2
Self-citationGiamouzis, G., Triposkiadis, F. K., Georgiopoulou, V. V., Farmakis, D. T., Westermann, D., & Skoularigis, J. S. (2013) · Cardiology Research and Practice · doi:10.1155/2013/342316 · Cited by 2
Adaptive Servoventilation in Treatment of Sleep-Disordered Breathing
Kuźniar, T. J., & Morgenthaler, T. I. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-378610-4.00360-0 · Cited by 2
Hamilton, G. S., Edwards, B. A., & Sands, S. A. (2013) · Respirology · doi:10.1111/resp.12216 · Cited by 2
van der Maaten, J. M., & Wijkstra, P. J. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr118 · Cited by 2
“Among the many therapies that have been shown to improve the severity of SDB, only positive pressure ventilation is associated with an improvement in cardiac function.(5) Sleep-disordered breathing can be effectively treated with various forms of positive-pressure ventilation therapy.”
BackgroundInsomnia Secondary to Sleep-Related Breathing Disorders
Judd, B. G. (2007) · Humana Press eBooks · doi:10.1007/978-1-60327-042-7_19 · Cited by 2
“Furthermore, one of the largest trials evaluating positive pressure therapy treatment for heart patients with central sleep apnea did not demonstrate any improvements in quality of life in patients treated with CPAP therapy, despite significant declines in the apnea–hypopnea index [19].”
BackgroundDoes What Happens During Sleep Matter for the Failing Heart? ∗
Cowie, M. (2015) · JACC Heart Failure · doi:10.1016/j.jchf.2015.10.014 · Cited by 2
Central Sleep Apnea in Heart Failure
Fang, J. C.-T., & Vidic, A. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.02.006 · Cited by 2
“In 2005, the CANPAP (Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure) trial (5) was the first randomized study to specifically target patients with predominantly CSA rather than OSA.”
Update in Sleep and Control of Ventilation 2005
Horner, R. L., & Bradley, T. D. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2601005 · Cited by 2
Self-citationYu, Y., Jackson, S. L., Björnsdóttir, E., & Oulton, C. (2020) · medRxiv · doi:10.1101/2020.05.15.20096404 · Cited by 2
Sex‐related difference in sympathetic chemoreflex response: does it matter in clinical disease?
Gentile, F., Emdin, M., Passino, C., & Giannoni, A. (2022) · The Journal of Physiology · doi:10.1113/jp283643 · Cited by 2
“Indeed, women have been extremely under-represented in the main clinical trials conducted in HF patients with PB/CA/CSR which tested the prognostic effects of non-invasive ventilation, yielding disappointing results (Bradley et al., 2005; Cowie et al., 2015).”
Novel Device Therapies for Heart Failure
Alkhatib, D. A., Isa, S. O., Pour‐Ghaz, I., Butt, A. K., Al-Taweel, O., Ugonabo, I., Yedlapati, N., & Jefferies, J. L. (2023) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd10040165 · Cited by 2
“Treatment of SDB with continuous positive airway pressure and adaptive servoventilation has generated mixed outcomes thus far [13,14] However, multiple studies have demonstrated the safety and efficacy of phrenic nerve stimulation (PNS) therapy in improving the quality of life of patients with HF, regardless of the LV…”
BackgroundSeet, E. C. P., & Chung, F. F. (2017) · Springer eBooks · doi:10.1007/978-1-4939-6578-6_35 · Cited by 1
Positive Airway Pressure in the Treatment of Sleep Apnea-Hypopnea
SANDERS, M. H., Strollo, P. J., Atwood, C. W., Stiller, R. A., & O'Donnell, C. P. (2009) · Elsevier eBooks · doi:10.1016/b978-0-7506-7584-0.00025-2 · Cited by 1
Dysfonction cardiaque et syndrome d’apnée du sommeil
Bocquillon, V., Destors, M., Guzun, R., Doutreleau, S., Pépin, J., & Tamisier, R. (2019) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2019.07.011 · Cited by 4
Bekfani, T., Abraham, J. D., & Abraham, W. T. (2025) · Cardiac failure review · doi:10.15420/cfr.2025.07 · Cited by 1
“13,39,40 However, CPAP is associated with haemodynamic disadvantages, particularly on the right ventricle, which compromises the already reduced ventricular output in patients with HF, ultimately leading to further deterioration of cardiac function.”
Impact of Hypopnoea Classifications on the Assessment of Sleep Disordered Breathing in Heart Failure
Baillieul, S., Tamisier, R., & Pépin, J. (2025) · Cardiac failure review · doi:10.15420/cfr.2025.37 · Cited by 2
Phrenic Nerve Stimulation for Central Sleep Apnoea: When and Why?
Na, J. S., Valderrábano, M., & Schurmann, P. A. (2025) · Cardiac failure review · doi:10.15420/cfr.2025.32 · Cited by 1
Research priorities to improve classification of sleep-wake disorders
Sateia, M. J., Abbott, S. M., Auger, R. R., Chervin, R. D., Donovan, L. M., Högl, B., Kimoff, R. J., Lichstein, K. L., Manber, R., Manconi, M., et al. (2026) · Journal of Clinical Sleep Medicine · doi:10.1007/s44470-025-00020-4 · Cited by 1
“Similarly, large randomized trials of positive airway pressure to treat heart failure patients with CSA/CSB have not demonstrated clinically meaningful improvements in symptoms, quality of life, hospitalizations, or cardiovascular events [ 84 , 100 – 102 ].”
Self-citationFloras, J. S., Logan, A. G., Tomlinson, G., Bradley, T. D., Bradley, T. D., Floras, J. S., Logan, A. G., Ryan, C. M., Delgado, D. H., Mak, S., et al. (2026) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2026.03.019 · Cited by 1
Self-citationŠipoš, I. H., Vergles, M., Lalić, K., Marasović, I., Rotkvić, P. G., Gulin, P., Romić, Z. Č., Đuzel, A., Batinjan, G., & Šipoš, K. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15145451 · Cited by 1
“In CSA, therapeutic interventions frequently improve respiratory parameters and surrogate physiological markers, but these effects have yet to consistently translate into durable improvements in quality of life or major clinical outcomes [28,72,73,75].”
InfluentialRosen, M., & Goldberg, L. R. (2026) · Cardiac failure review · doi:10.15420/cfr.2025.47 · Cited by 1
“43,44 In a randomised trial of 55 patients with HF and OSA, 3 months of nightly CPAP improved LVEF.”
Oxygen overshoot burden of central sleep apnea and its association with cardiovascular outcomes
Azarbarzin, A., McKane, S. W., Stone, K. L., Germany, R. E., Redline, S. S., & Malhotra, A. (2026) · Journal of Clinical Sleep Medicine · doi:10.1007/s44470-026-00161-0 · Cited by 1
“The treatment of central apnea has been controversial since the existing studies have shown mixed results regarding long-term outcomes [55–57].”
Non-positive Airway Pressure Therapies for Obstructive Sleep Apnoea and Central Sleep Apnoea
Mora, J., Sunwoo, B. Y., Ramsis, M., & Malhotra, A. (2026) · Cardiac failure review · doi:10.15420/cfr.2025.24 · Cited by 1
Avdeev, S. N., Popova, K. A., Nekludova, G. V., & Чучалин, А. Г. (2011) · PULMONOLOGIYA · doi:10.18093/0869-0189-2011-0-2-41-48 · Cited by 1
Sleep-disordered breathing as a modifiable risk factor for cardiovascular disease
Pleister, A. P., & Khayat, R. (2015) · Current Pulmonology Reports · doi:10.1007/s13665-015-0102-z · Cited by 1
Central sleep apnea detection and stimulation
Kinio, S. C., Islam, M., & Qasim, T. (2011) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/iembs.2011.6091879 · Cited by 1
“them oxygenated, regardless of if their respiratory muscles are actually functioning [8].”
BackgroundTreatment Options for Cheyne-Stokes Respiration and Heart Failure
Sasayama, S. (2011) · Current Heart Failure Reports · doi:10.1007/s11897-011-0058-4 · Cited by 1
Sankatsing, S. U. C., Hanselaar, W., van Steenwijk, R. P., van der Sloot, J. A. P., Broekhuis, E., & Kok, W. E. M. (2008) · Netherlands Heart Journal · doi:10.1007/bf03086170 · Cited by 1
Arcos, J. P., Baz, M., Lorenzo, D., Chiappella, L., & Otaño, N. (2008) · Revista Uruguaya de Cardiología · Cited by 1
Noninvasive Ventilation on Heart Failure
Quintão, M., Bastos, A. F., da Silva, L. M., Bernardez, S., Martins, W. D. A., Mesquita, E. T., Soares, S. L. M., & Chermont, M. (2009) · Cited by 1
Thorpy, M. J., Lieberman, J. A., Roth, T. G., & Owens, G. S. (2007) · PubMed · Cited by 1
Klasyfikacja, Obraz Kliniczny i Diagnostyka Zaburzeń Oddychania w Czasie Snu
Chazan, R. (2007) · Advances in respiratory medicine · doi:10.5603/arm.27936 · Cited by 1
Kasai, T. (2015) · Springer eBooks · doi:10.1007/978-3-319-21653-9_88 · Cited by 1
Sleep apnea syndrome and heart failure—mechanisms and consequences
Ardelean, C. L., Lighezan, D., Pescariu, S., Nădășan, V., Pleava, R. M., & Mihaicuta, S. D. (2019) · Pneumologia · doi:10.2478/pneum-2019-0017 · Cited by 1
Designing an Intelligent System for Diagnosing Type of Sleep Apnea and Determining Its Severity
Kohzadi, Z., Safdari, R., & Sadeghniiat‐Haghighi, K. (2021) · Frontiers in Health Informatics · doi:10.30699/fhi.v10i1.287 · Cited by 1
“Sleep apnea is a disorder in which breathing is repeatedly interrupted during sleep and starts again [1].”
BackgroundValvular Heart Disease in Pregnancy
Stout, K., & Krieger, E. V. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4860-0.00027-x · Cited by 2
Oldenburg, O., Bitter, T., Fox, H., Spießhöfer, J., Türoff, A., & Horstkotte, D. (2014) · Der Pneumologe · doi:10.1007/s10405-014-0794-8 · Cited by 2
Lari, F., Giostra, F., Bragagni, G., & Battista, N. D. (2009) · Italian Journal of Medicine · doi:10.4081/itjm.2009.201 · Cited by 1
Snoring, Irregular Respiration, Hypoventilation, and Apneas
Ogunrinde, O. (2014) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2014.08.002 · Cited by 1
Central Sleep Apnea: From Pathophysiology to Clinical Management
Schaffernocker, T., Morrison, J., & Khayat, R. (2014) · Cited by 1
Yancy, C. W., Jessup, M. L., Bozkurt, B., Butler, J., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T. B., Januzzi, J. L., Johnson, M. R., et al. (2013) · Cited by 1
Central Sleep Apnea: Implications for the Failing Heart
Somers, V. K. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-421-6_7 · Cited by 1
Coats, A. J. S., & Shewan, L. G. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.02.123 · Cited by 1
Management of Non-cardiac Co-morbidities in Chronic Heart Failure
Lang, C. C., & MANCINI, D. M. (2015) · Springer eBooks · doi:10.1007/978-1-4471-6657-3_12 · Cited by 1
Positive-pressure treatment of obstructive sleep apnea syndrome
Buchanan, P. R., & Grunstein, R. R. (2010) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52006-7.00028-9 · Cited by 1
Central Sleep Apnoea (CSA) in Male with Heart Failure
Pływaczewski, R., Czerniawska, J., Bieleń, P., Bednarek, M., Górecka, D., & Śliwiński, P. (2006) · Advances in respiratory medicine · doi:10.5603/arm.28023 · Cited by 1
“W dużym, niedawno ukończonym prospektywnym badaniu kanadyjskim (258 chorych obserwowanych przez 2 lata: 130 zakwalifi kowanych do CPAP, 128 bez CPAP) odsetek chorych, którzy zmarli lub wymagali przeszczepu serca, był podobny w obydwu grupach [4].”
Background
Metadata
- Authors
- Bradley, T. D., Logan, A. G., Kimoff, R. J., Sériès, F., Morrison, D., Ferguson, K., Belenkie, I., Pfeifer, M., Fleetham, J., Hanly, P., Smilovitch, M., Tomlinson, G., & Floras, J. S.
- Affiliations
- University of Toronto (CA)
- McGill University (CA)
- Université Laval (CA)
- Dalhousie University (CA)
- Western University (CA)
- University of Calgary (CA)
- University of Regensburg (DE)
- University of British Columbia (CA)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-11-10
- Volume
- 353
- Issue
- 19
- Pages
- 2025-2033
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2130637800
- Semantic Scholar
- 266ff6f4028ab04f061c1b59c2a17a2fc2990e32
- Cited by
- 1,189
- References
- 45
- Citations by year
- 2026: 16 · 2025: 31 · 2024: 33 · 2023: 47 · 2022: 45 · 2021: 51 · 2020: 40 · 2019: 55 · 2018: 50 · 2017: 70 · 2016: 87 · 2015: 68 · 2014: 44 · 2013: 67 · 2012: 62
- FWCI
- 45.16
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory Support and Mechanisms
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Keywords
- continuous positive airway pressure, central sleep apnea, heart failure, nocturnal oxygen saturation, norepinephrine, ejection fraction, exercise capacity, neurohormones, atrial natriuretic peptide, quality of life, heart transplantation, sleep-disordered breathing, heart failure with reduced ejection fraction, heart failure with preserved ejection fraction
- MeSH terms
- Aged, Female, Follow-Up Studies, Heart Failure, Humans, Male, Middle Aged, Norepinephrine, Stroke Volume, Survival Rate, Proportional Hazards Models, Heart Transplantation, Treatment Outcome, Exercise Tolerance, Sleep Apnea, Central, Continuous Positive Airway Pressure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.